Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Distribute iCAD TotalLook System for Growing Digital Mammography Market

10.03.2006


iCAD’s TotalLook Product Supports Enhanced Comparative Review of Prior Film and Current Digital Mammograms When Converting to Digital Mammography

... mehr zu:
»DICOM

iCAD®, Inc. (Nasdaq: ICAD), an industryleading provider of Computer Aided Detection (CAD) solutions, and Siemens Medical Solutions, a world leader in medical imaging and information technology (IT) solutions, have announced that Siemens will offer iCAD’s TotalLook system as an option for use with its MAMMOMAT® NovationDR full-field digital mammography system, through Siemens global sales and distribution channels. TotalLook, introduced by iCAD at the end of 2005, provides customers with a comprehensive film-to-digital solution making it easier for women’s health centers to transition from film to digital mammography.

This new technology assists radiologists in comparing breast images year-to-year to detect subtle changes that may be indicative of breast cancer. Based on successful installations of iCAD systems with its customers, Siemens made the decision to offer the TotalLook system as an option for its digital mammography customers. Siemens also distributes iCAD’s Second Look Digital solution for computer aided detection of breast cancer.


TotalLook converts prior film images into a digital format for comparison with more recent images from digital mammography systems. It automatically adjusts the digitized images for correct display on Siemens’ MammoReportPlus softcopy reporting workstation. By providing radiologists with a “total look” at a patient’s multi-year mammograms, the solution helps detect subtle changes that may be indicative of breast cancer. In addition, it eliminates the need to shift back and forth from a light box to a digital workstation increasing workflow and improving productivity. The TotalLook solution has the capability to:

• Automatically retrieve and receive patient information from HL-7 or DICOM worklists • Digitize standard mammography films in 23 seconds • Capture the full fidelity of original film mammograms in each digitized image • Track and label records in industry-standard DICOM format • Send complete records to multiple DICOM destinations simultaneously • Display high-resolution digitized images on many DICOM workstations in any hanging protocol

About Siemens Medical Solutions

Siemens Medical Solutions of Siemens AG (NYSE: SI) with headquarters in Malvern, Pennsylvania, and Erlangen, Germany, is one of the largest suppliers to the healthcare industry in the world. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Employing approximately 33,000 people worldwide and operating in more than 120 countries, Siemens Medical Solutions reported sales of 7.6 billion EUR, orders of 8.6 billion EUR and group profit of 976 million EUR for fiscal 2005.

About iCAD, Inc.

iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to identify cancer and other life-threatening conditions earlier by making medical services more effective, more accessible and more affordable for patients worldwide. Recipient of Frost & Sullivan’s Growth Strategy Leadership award, iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over eleven hundred women’s healthcare centers worldwide.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:

Certain statements contained in this News Release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forwardlooking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company’s filings with the Securities and Exchange Commission. The words “believe”, “demonstrate”, “intend”, “expect”, “estimate”, “anticipate”, “likely”, and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.

iCAD and Second Look are registered trademarks of iCAD, Inc.

For iCAD investor relations, contact Kevin McGrath of Cameron Associates at +1 212-245-4577 or via email at kevin@cameronassoc.com. For Siemens public relations, contact Amanda Naiman at +1 610-448-4531 or via email at amanda.naiman@siemens.com.

| Siemens AG
Weitere Informationen:
http://www.usa.siemens.com/medical-pressroom
http://www.icadmed.com

Weitere Berichte zu: DICOM

Weitere Nachrichten aus der Kategorie Medizin Gesundheit:

nachricht Innovative Antikörper für die Tumortherapie
20.02.2017 | Wilhelm Sander-Stiftung

nachricht Nervenschmerzen zukünftig wirksamer behandeln
20.02.2017 | Universität Zürich

Alle Nachrichten aus der Kategorie: Medizin Gesundheit >>>

Die aktuellsten Pressemeldungen zum Suchbegriff Innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Innovative Antikörper für die Tumortherapie

Immuntherapie mit Antikörpern stellt heute für viele Krebspatienten einen Erfolg versprechenden Ansatz dar. Weil aber längst nicht alle Patienten nachhaltig von diesen teuren Medikamenten profitieren, wird intensiv an deren Verbesserung gearbeitet. Forschern um Prof. Thomas Valerius an der Christian Albrechts Universität Kiel gelang es nun, innovative Antikörper mit verbesserter Wirkung zu entwickeln.

Immuntherapie mit Antikörpern stellt heute für viele Krebspatienten einen Erfolg versprechenden Ansatz dar. Weil aber längst nicht alle Patienten nachhaltig...

Im Focus: Durchbruch mit einer Kette aus Goldatomen

Einem internationalen Physikerteam mit Konstanzer Beteiligung gelang im Bereich der Nanophysik ein entscheidender Durchbruch zum besseren Verständnis des Wärmetransportes

Einem internationalen Physikerteam mit Konstanzer Beteiligung gelang im Bereich der Nanophysik ein entscheidender Durchbruch zum besseren Verständnis des...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: Hoch wirksamer Malaria-Impfstoff erfolgreich getestet

Tübinger Wissenschaftler erreichen Impfschutz von bis zu 100 Prozent – Lebendimpfstoff unter kontrollierten Bedingungen eingesetzt

Tübinger Wissenschaftler erreichen Impfschutz von bis zu 100 Prozent – Lebendimpfstoff unter kontrollierten Bedingungen eingesetzt

Im Focus: Sensoren mit Adlerblick

Stuttgarter Forscher stellen extrem leistungsfähiges Linsensystem her

Adleraugen sind extrem scharf und sehen sowohl nach vorne, als auch zur Seite gut – Eigenschaften, die man auch beim autonomen Fahren gerne hätte. Physiker der...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Die Welt der keramischen Werkstoffe - 4. März 2017

20.02.2017 | Veranstaltungen

Schwerstverletzungen verstehen und heilen

20.02.2017 | Veranstaltungen

ANIM in Wien mit 1.330 Teilnehmern gestartet

17.02.2017 | Veranstaltungen

 
VideoLinks
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Innovative Antikörper für die Tumortherapie

20.02.2017 | Medizin Gesundheit

Multikristalline Siliciumsolarzelle mit 21,9 % Wirkungsgrad – Weltrekord zurück am Fraunhofer ISE

20.02.2017 | Energie und Elektrotechnik

Wie Viren ihren Lebenszyklus mit begrenzten Mitteln effektiv sicherstellen

20.02.2017 | Biowissenschaften Chemie